Potential and Pitfalls of Pharmacovigilance Databases in Oncology

JACC CardioOncol. 2023 Feb 21;5(1):99-101. doi: 10.1016/j.jaccao.2022.12.003. eCollection 2023 Feb.

Authors

Ilana Schlam¹, Michael S Ewer², Sandra M Swain³

Affiliations

¹ Tufts Medical Center, Division of Hematology and Oncology, Boston, Massachusetts, USA.
² MD Anderson Cancer Center, Houston, Texas, USA.
³ Georgetown Lombardi Comprehensive Cancer Center and MedStar Health, Washington, DC, USA.

No abstract available

Keywords: Her2 therapy; breast cancer; heart failure; monoclonal antibody; tyrosine kinase inhibitor.

Publication types

Editorial